{"org_id": "Q00004157E", "org_name_cn": "上海凯赛生物技术股份有限公司", "org_short_name_cn": "凯赛生物", "org_name_en": "Cathay Biotech Inc.", "org_short_name_en": "Cathay Biotech", "main_operation_business": "新型生物基材料的研发、生产及销售", "operating_scope": "　　生物新材料单体和高分子聚合物、生物医药、食品和饲料添加剂等方面的技术研究、开发，技术转让、技术咨询（涉及许可经营的凭许可证经营）；生物新材料单体和高分子聚合物、生物技术产品（不含药品、食品、食品添加剂）的生产，销售自产产品。【依法须经批准的项目，经相关部门批准后方可开展经营活动】", "district_encode": "310115", "org_cn_introduction": "上海凯赛生物技术股份有限公司从事新型生物基材料的研发、生产及销售。公司目前主要产品为生物法长链二元酸系列产品、生物基戊二、胺生物基聚酰胺。公司获得过第三批制造业单项冠军产品、2018中国石油和化工民营企业百强、国家级两化融合管理体系贯标试点企业、《中国制造2025》重大项目、山东省瞪羚标杆企业、山东省工业提质增效升级专项奖等奖项。", "legal_representative": "刘修才", "general_manager": "刘修才", "secretary": "臧慧卿", "established_date": 974995200000, "reg_asset": 416681976.0, "staff_num": 1308, "telephone": "86-21-50801916", "postcode": "201203", "fax": "86-21-50801386", "email": "cathaybiotech_info@cathaybiotech.com", "org_website": "www.cathaybiotech.com", "reg_address_cn": "上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼", "reg_address_en": "", "office_address_cn": "上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1597161600000, "provincial_name": "上海市", "actual_controller": "XIUCAI LIU (14.44%)，XIAOWEN MA (14.44%)，CHARLIE CHI LIU (13.88%)", "classi_name": "外资企业", "pre_name_cn": null, "chairman": "刘修才", "executives_nums": 16, "actual_issue_vol": 41668198.0, "issue_price": 133.45, "actual_rc_net_amt": 5279993800.0, "pe_after_issuing": 120.7, "online_success_rate_of_issue": 0.03509634, "affiliate_industry": {"ind_code": "BK0009", "ind_name": "化学制品"}}